# A Clinical Study of RSS0343 in Healthy Subjects

> **NCT07289464** · PHASE1 · RECRUITING · sponsor: **Reistone Biopharma Company Limited** · enrollment: 48 (estimated)

## Conditions studied

- Non-cystic Fibrosis Bronchiectasis

## Interventions

- **DRUG:** RSS0343 Tablets
- **DRUG:** RSS0343 Tablets Placebo

## Key facts

- **NCT ID:** NCT07289464
- **Lead sponsor:** Reistone Biopharma Company Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-01-04
- **Primary completion:** 2026-09
- **Final completion:** 2026-09
- **Target enrollment:** 48 (ESTIMATED)
- **Last updated:** 2026-01-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07289464

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07289464, "A Clinical Study of RSS0343 in Healthy Subjects". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07289464. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*